Erwan Le Scolan

552 total citations
15 papers, 446 citations indexed

About

Erwan Le Scolan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Erwan Le Scolan has authored 15 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Erwan Le Scolan's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Erythrocyte Function and Pathophysiology (2 papers) and TGF-β signaling in diseases (2 papers). Erwan Le Scolan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Erythrocyte Function and Pathophysiology (2 papers) and TGF-β signaling in diseases (2 papers). Erwan Le Scolan collaborates with scholars based in United States, France and Netherlands. Erwan Le Scolan's co-authors include Kunxin Luo, Qingwei Zhu, Alain Mauviel, Delphine Javelaud, Xiao‐Dan Ji, Françoise Moreau-Gachelin, Nicole Denis, William Vainchenker, Thierry Levade and Patrick Mayeux and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Erwan Le Scolan

15 papers receiving 438 citations

Peers

Erwan Le Scolan

ONCOL

PHYSI

Lorena Agudo‐Ibáñez Spain

Sue-Chin Lee United States

Laura Wolgamott United States

Hyun-Jin Shin South Korea

Eri Asano Japan

Ryuzaburo Yuki Japan

Sushma‐Nagaraja Grellscheid United Kingdom

Matthew Wherlock United Kingdom

N Li China

Sreesha P. Srinivasa United States

Lorena Agudo‐Ibáñez Spain

Erwan Le Scolan

382 ×1.1

146 ×0.9

75 ×0.9

ONCOL

39 ×1.1

21 ×0.6

PHYSI

Citations per year, relative to Erwan Le Scolan Erwan Le Scolan (= 1×) peers Lorena Agudo‐Ibáñez

Countries citing papers authored by Erwan Le Scolan

Since Specialization

Citations

This map shows the geographic impact of Erwan Le Scolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwan Le Scolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwan Le Scolan more than expected).

Fields of papers citing papers by Erwan Le Scolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwan Le Scolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwan Le Scolan. The network helps show where Erwan Le Scolan may publish in the future.

Co-authorship network of co-authors of Erwan Le Scolan

This figure shows the co-authorship network connecting the top 25 collaborators of Erwan Le Scolan. A scholar is included among the top collaborators of Erwan Le Scolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwan Le Scolan. Erwan Le Scolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Berezhnoy, Alexey, Hsin Wang, Na Cai, et al.. (2022). 1078 Conditionally activatable interferon-alpha 2b improves tolerability and exhibits preferential activity in tumors. Regular and Young Investigator Award Abstracts. A1120–A1120. 1 indexed citations

Berezhnoy, Alexey, Hsin Wang, Michael B. Winter, et al.. (2022). Abstract 2071: Probody-interferon-alpha 2b combines antitumor activity with improved tolerability. Cancer Research. 82(12_Supplement). 2071–2071. 1 indexed citations

Berezhnoy, Alexey, Hsin Wang, Hikmat Assi, et al.. (2021). 706 Conditional cytokine therapeutics for tumor-selective biological activity: preclinical characterization of a dual-masked IFN-a2b. SHILAP Revista de lepidopterología. A735–A735. 6 indexed citations

Scolan, Erwan Le, Tiffany Tse, Michael Krimm, et al.. (2019). Abstract 3202: A probody drug conjugate targeting CD166 (ALCAM) enhances preclinical antitumor activity of a probody therapeutic targeting PD-1. Cancer Research. 79(13_Supplement). 3202–3202. 2 indexed citations

Argast, Gretchen, Belinda Cancilla, Fiore Cattaruzza, et al.. (2018). Abstract 5627: Anti-TIGIT biomarker study: Inhibition of TIGIT induces loss of Tregs from tumors and requires effector function for tumor growth inhibition. Cancer Research. 78(13_Supplement). 5627–5627. 4 indexed citations

Cattaruzza, Fiore, Min Wang, Alayne Brunner, et al.. (2017). Abstract 599: Pharmacodynamic biomarkers for anti-TIGIT treatment and prevalence of TIGIT expression in multiple solid tumor types. Cancer Research. 77(13_Supplement). 599–599. 2 indexed citations

Zhu, Qingwei, Erwan Le Scolan, Nadine S. Jahchan, et al.. (2016). SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis. Developmental Cell. 37(5). 399–412. 31 indexed citations

Rashidian, Juliet, Erwan Le Scolan, Xiao‐Dan Ji, et al.. (2015). Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Science Signaling. 8(363). ra14–ra14. 54 indexed citations

Mulvihill, Melinda M., Daniel I. Benjamin, Xiao‐Dan Ji, et al.. (2014). Metabolic Profiling Reveals PAFAH1B3 as a Critical Driver of Breast Cancer Pathogenicity. Chemistry & Biology. 21(7). 831–840. 40 indexed citations

10.

Javelaud, Delphine, Léon C.L.T. van Kempen, Vasileia Ismini Alexaki, et al.. (2011). Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Molecular Cancer. 10(1). 2–2. 43 indexed citations

11.

Scolan, Erwan Le, Qingwei Zhu, Long Wang, et al.. (2008). Transforming Growth Factor-β Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation. Cancer Research. 68(9). 3277–3285. 85 indexed citations

12.

Scolan, Erwan Le, et al.. (2005). Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene. Oncogene. 25(9). 1420–1423. 23 indexed citations

13.

Scolan, Erwan Le, Dmitri Pchejetski, Yoshiko Banno, et al.. (2005). Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood. 106(5). 1808–1816. 89 indexed citations

14.

Leprince, Corinne, Erwan Le Scolan, Brigitte Meunier, et al.. (2003). Sorting nexin 4 and amphiphysin 2, a new partnership between endocytosis and intracellular trafficking. Journal of Cell Science. 116(10). 1937–1948. 60 indexed citations

15.

Scolan, Erwan Le, Fabrice Wendling, Nicole Denis, et al.. (2001). Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts. Oncogene. 20(39). 5484–5492. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact